The effect of cold atmospheric plasma on invasive ductal tumors of the breast.. breast cancer/neoadjuvant therapy/cold atmospheric plasma/
Conditions
Interventions
Intervention group: cold atmospheric plasma.
Sponsors
Iran University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
35 Years to 70 Years
Inclusion criteria
Inclusion criteria: patient with breast cancer(IDC) Be a candidate for neoadjuvant therapy Have a measurable mass in breast Between 35 and 70 years old
Exclusion criteria
Exclusion criteria: The patient cannot tolerate preoperative chemotherapy for medical reasons. The patient is unwilling to participate in the study. The patient's tumor is not a measurable mass and is only microcalcifications. A patient who does not consent to preoperative chemotherapy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reducing tumor size by injecting cold atmospheric plasma into it. Timepoint: One month after the plasma is injected into the tumor, a re-measurement is performed, and three months after the start of chemotherapy, surgery, and final pathology are determined. Method of measurement: sonography. | — |
Secondary
| Measure | Time frame |
|---|---|
| Investigating the effect of plasma on final pathology results, such as the extent of tumor invasion into blood vessels and nerves. Timepoint: Measurement of tumor size before plasma injection and one month after injection. Method of measurement: sonography. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public Contactsoheila sayad
Iranshahr University of Medical Sciences
Outcome results
None listed